Characteristics of patients with venous thrombosis and control subjects
. | Patients . | Control subjects . | P*; OR (95% CI) . |
|---|---|---|---|
| N | 1018 | 1018 | |
| Age, y (range) | 49 (36-62) | 47 (35-63) | .618 |
| Male sex, no | 509 | 509 | .999 |
| FV Leiden, no. | < .001; 5.29 (3.5-8.0) | ||
| −/− | 873 | 987 | |
| +/− & +/+ | 142 & 3 | 31 & 0 | |
| PT 20210, no. | < .001; 4.20 (2.7-6.7) | ||
| G/G | 917 | 992 | |
| G/A & A/A | 94 & 7 | 26 & 0 | |
| ZPI 603 (Lys25Arg), no. | .113 | ||
| A/A | 295 | 328 | |
| A/G & G/G | 522 & 201 | 525 & 165 | |
| ZPI 647 (Ser40Gly), no. | .959 | ||
| A/A | 759 | 758 | |
| A/G & G/G | 246 & 13 | 249 & 11 | |
| ZPI 728 (Arg67Stop), no. | < .001; 3.40 (1.5-7.8) | ||
| C/C | 988 | 1009 | |
| C/T & T/T | 29 & 1 | 9 & 0 | |
| ZPI 1277 (Gly250Ser), no. | < .001; 3.01 (1.6-5.8) | ||
| G/G | 977 | 1004 | |
| G/A & A/A | 40 & 1 | 14 & 0 |
. | Patients . | Control subjects . | P*; OR (95% CI) . |
|---|---|---|---|
| N | 1018 | 1018 | |
| Age, y (range) | 49 (36-62) | 47 (35-63) | .618 |
| Male sex, no | 509 | 509 | .999 |
| FV Leiden, no. | < .001; 5.29 (3.5-8.0) | ||
| −/− | 873 | 987 | |
| +/− & +/+ | 142 & 3 | 31 & 0 | |
| PT 20210, no. | < .001; 4.20 (2.7-6.7) | ||
| G/G | 917 | 992 | |
| G/A & A/A | 94 & 7 | 26 & 0 | |
| ZPI 603 (Lys25Arg), no. | .113 | ||
| A/A | 295 | 328 | |
| A/G & G/G | 522 & 201 | 525 & 165 | |
| ZPI 647 (Ser40Gly), no. | .959 | ||
| A/A | 759 | 758 | |
| A/G & G/G | 246 & 13 | 249 & 11 | |
| ZPI 728 (Arg67Stop), no. | < .001; 3.40 (1.5-7.8) | ||
| C/C | 988 | 1009 | |
| C/T & T/T | 29 & 1 | 9 & 0 | |
| ZPI 1277 (Gly250Ser), no. | < .001; 3.01 (1.6-5.8) | ||
| G/G | 977 | 1004 | |
| G/A & A/A | 40 & 1 | 14 & 0 |
Crude analysis; OR is given when P < .05.